- Home
- SENS
as 01-17-2025 4:00pm EST
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.
| Founded: | 1996 | Country: | United States |
| Employees: | N/A | City: | GERMANTOWN |
| Market Cap: | 179.7M | IPO Year: | N/A |
| Target Price: | $2.00 | AVG Volume (30 days): | 18.7M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.13 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.25 - $0.93 | Next Earning Date: | 02-27-2025 |
| Revenue: | $22,205,000 | Revenue Growth: | 11.41% |
| Revenue Growth (this year): | 0.12% | Revenue Growth (next year): | 61.22% |
Stock Insider Trading Activity of Senseonics Holdings Inc. (SENS)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Sullivan Frederick T. | SENS | Chief Financial Officer | Dec 12 '24 | Buy | $0.38 | 124,933 | $47,474.54 | 2,478,844 | |
| ROEDER DOUGLAS A | SENS | Director | Dec 12 '24 | Buy | $0.47 | 400,000 | $173,000.00 | 1,463,087 | |
| Goodnow Timothy T | SENS | President and CEO | Dec 10 '24 | Buy | $0.31 | 315,000 | $97,650.00 | 11,310,355 |
Latest Senseonics Holdings Inc. News
SENS Breaking Stock News: Dive into SENS Ticker-Specific Updates for Smart Investing
GuruFocus.com
10 days ago
Senseonics Stock Surges 42% After Hours on Preliminary Revenue Report
GlobeNewswire
11 days ago
Senseonics Holdings, Inc. Announces Business Updates Including Preliminary 2024 Results, 365 Launch Update and Cancellation of Special Meeting
Insider Monkey
13 days ago
Here’s Why Senseonics Holdings, Inc. (NYSE:SENS) Is Among the Best Diabetes Stocks to Buy Under $10
GlobeNewswire
a month ago
Senseonics Holdings, Inc. Provides Update on Eversense 365 Launch
MT Newswires
2 months ago
Senseonics Discloses Plans for Secondary Offering
GlobeNewswire
2 months ago
Senseonics Holdings, Inc. to Participate in Upcoming Investor Conferences
GuruFocus.com
2 months ago
Senseonics Holdings Inc (SENS) Q3 2024 Earnings Call Highlights: Navigating Revenue Challenges ...
Zacks
2 months ago
Senseonics Holdings (SENS) Reports Q3 Loss, Tops Revenue Estimates
Compare SENS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SENS Senseonics Holdings Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.